Emcure Pharmaceuticals schedules Q2 FY27 earnings call for November 3, 2026

Board & Shareholder Meetings View source PDF Explain this filing

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.3%Reaction day

₹1860.00

prior close

₹1860.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-1.2%-0.1% vs market

Pharmaceuticals peers, median of 172sector-0.6%-0.7% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+0.4

15m

+0.0

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.3-1.2-0.1-0.6-0.7

Next day

-2.0-1.1-1.0-0.7-1.4

-4.9-2.2-2.7-1.9-3.0

-5.5-4.4-1.1-3.5-2.0

-4.3-5.5+1.2-4.4+0.1

-4.5-8.1+3.6-6.1+1.5

+0.3pendingpending-2.9+3.2

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Emcure Pharmaceuticals will hold an earnings call on Tuesday, November 3, 2026 at 4:00 PM IST via Zoom Webinar to discuss the unaudited financial results (standalone and consolidated) and performance for the quarter and half-year ended September 30, 2026. The recording and transcript will be posted on the company website within 24 hours and 5 working days respectively.

Likely market impact

Investor awareness event set for November 3. Watch for Q2 FY27 results, management commentary on business outlook, and any forward guidance from the pharma company.